http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010101307-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14 |
filingDate | 2008-06-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2011-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2010101307-A |
titleOfInvention | SUBSTITUTED (OXAZOLIDINON-5IL-METHYL) -2-THIOPHENE-CARBOXAMIDES AND THEIR APPLICATION IN THE FIELD OF BLOOD COAGING |
abstract | 1. The compound of the formula! ! wherein ! R1 is chloro, trifluoromethoxy, methyl, ethyl, n-propyl, methoxy, methoxymethyl or ethoxymethyl,! R2 is hydrogen or methyl! and! R3 means a group of formulas! or , ! where! * means the place of attachment to the ring of oxopyridine,! n means the number 1, 2, 3 or 4,! m means the number 1 or 2,! R4 is hydrogen, methyl, ethyl, cyclopropyl, cyclobutyl, 2-hydroxyeth-1-yl, 3-hydroxyprop-1-yl, 2-methoxyeth-1-yl, 3-methoxyprop-1-yl, 4-hydroxycyclohex-1- silt, tetrahydrofuran-2-ylmethyl or 1,4-dioxan-2-ylmethyl! R5 means hydrogen, methyl or ethyl! or ! R4 and R5 together with the nitrogen atom to which they are attached form a pyrrolidin-1-yl ring, a 2-methoxymethyl-pyrrolidin-1-yl ring, a morpholin-4-yl ring, a 1,1-dioxo-thiomorpholin-4- ring sludge, 1,4-oxazepan-4-yl ring, 4-methyl-piperazin-1-yl or 4-hydroxy-piperidin-1-yl ring,! R6 is hydrogen, methyl, ethyl, cyclopropyl, cyclobutyl, 2-hydroxyeth-1-yl, 3-hydroxyprop-1-yl, 2-methoxyeth-1-yl, 3-methoxyprop-1-yl, 4-hydroxycyclohex-1- silt, tetrahydrofuran-2-ylmethyl or 1,4-dioxan-2-ylmethyl! R7 means hydrogen, methyl or ethyl! R6 and R7 together with the nitrogen atom to which they are attached form a pyrrolidin-1-yl ring, a 2-methoxymethyl-pyrrolidin-1-yl ring, a morpholin-4-yl ring, a 1,1-dioxo-thiomorpholin-4- ring sludge, 1,4-oxazepan-4-yl ring, 4-methyl-piperazin-1-yl or 4-hydroxy-piperidin-1-yl ring,! or one of its salts, one of its solvates or solvates of their salts. ! 2. The compound according to claim 1, characterized in that! R1 is chloro, trifluoromethoxy, methyl, ethyl, n-propyl, methoxy or methoxymethyl,! R2 is hydrogen or methyl, and! R3 means a group of formulas! or , ! where! * means a place attached� |
priorityDate | 2007-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.